


Healthcare News Roundup: FDA
HSMN NewsFeed - 26 Jan 2011
U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra for Over-The-Counter Use
U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra for Over-The-Counter Use
HSMN NewsFeed - 26 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
HSMN NewsFeed - 20 Jan 2011
Spectranetics Receives FDA Approval for Site Change Related to Manufacturing of CVX-300(R) Laser System
Spectranetics Receives FDA Approval for Site Change Related to Manufacturing of CVX-300(R) Laser System
HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
HSMN NewsFeed - 13 Jan 2011
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
HSMN NewsFeed - 6 Jan 2011
Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
HSMN NewsFeed - 22 Dec 2010
Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
HSMN NewsFeed - 15 Dec 2010
Accuray Receives FDA Clearance for the CyberKnife(R) System's Lung Optimized Treatment
Accuray Receives FDA Clearance for the CyberKnife(R) System's Lung Optimized Treatment
HSMN NewsFeed - 14 Dec 2010
FDA Grants Hemispherx Biopharma Extension in Its Pending NDA for Treatment of Chronic Fatigue Syndrome (CFS)
FDA Grants Hemispherx Biopharma Extension in Its Pending NDA for Treatment of Chronic Fatigue Syndrome (CFS)
HSMN NewsFeed - 13 Dec 2010
Clear Catheter Systems Receives US FDA Clearance for the PleuraFlow Active Tube Clearance System
Clear Catheter Systems Receives US FDA Clearance for the PleuraFlow Active Tube Clearance System
HSMN NewsFeed - 7 Dec 2010
Orthovita Receives FDA Clearance for Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute
Orthovita Receives FDA Clearance for Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute
HSMN NewsFeed - 3 Dec 2010
CONMED Corporation Receives Clearance From FDA for Novel Tissue Fusion System
CONMED Corporation Receives Clearance From FDA for Novel Tissue Fusion System
HSMN NewsFeed - 3 Dec 2010
Oceana Therapeutics Announces FDA Advisory Committee Recommends Approval of Solesta(TM)
Oceana Therapeutics Announces FDA Advisory Committee Recommends Approval of Solesta(TM)
HSMN NewsFeed - 2 Dec 2010
MedPro Safety Products Receives FDA Market Clearance for Passive Safety Winged Blood Collection Set
MedPro Safety Products Receives FDA Market Clearance for Passive Safety Winged Blood Collection Set
HSMN NewsFeed - 2 Dec 2010
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
HSMN NewsFeed - 2 Dec 2010
Covidien Receives FDA 510(k) Clearance for the iDrive(TM) Powered Stapling System
Covidien Receives FDA 510(k) Clearance for the iDrive(TM) Powered Stapling System
HSMN NewsFeed - 1 Dec 2010
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
HSMN NewsFeed - 1 Dec 2010
Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex(R) for Fast Track Development
Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex(R) for Fast Track Development
